100
Participants
Start Date
May 11, 2021
Primary Completion Date
June 30, 2026
Study Completion Date
June 30, 2026
Alcohol
Participants will complete three experimental sessions. In each session, participants will provide detailed reports of their alcohol consumption over the past five days, and they will provide a blood sample for hormone assays. They will perform tasks during fMRI to assess each of the neurofunctional addiction domains: inhibitory control, negative emotionality, and cue reactivity. Following the fMRI scan, subjects will self-administer intravenous alcohol to provide a controlled assessment of pharmacologically-driven alcohol consumption.
RECRUITING
The Ohio State University, Columbus
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
NIH
Jessica Weafer
OTHER